How have you adjusted your clozapine prescribing and monitoring practices in response to changes in REMS requirements?

After the discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy (REMS) requirement in 2025, have your clozapine monitoring practices shifted? Have you changed how frequently you order lab monitoring? What resources or guidance have you used in making these decisions? Has your threshold for prescribing clozapine changed in light of these updates?